Sonoda 2021.
Study characteristics | |||
Patient Sampling |
Purpose: diagnosis of SARS‐CoV‐2 infection (mild COVID‐19 disease); to investigate the clinical symptoms to discriminate between COVID‐19 and non‐COVID‐19 cases among outpatients in GP clinics Design: cross‐sectional cohort study, retrospective data collection Recruitment: outpatients visiting the screening centre (GP clinic) Sample size: n = 360 (17 cases) Inclusion criteria: patients visiting the centre with suspicion of COVID‐19 (no definition of 'suspicion') Exclusion criteria: patients who didn't receive a RT‐PCR test |
||
Patient characteristics and setting |
Facility cases: positive RT‐PCR for SARS‐CoV‐2 Facility controls: negative RT‐PCR for SARS‐CoV‐2 Country: Japan Dates: 01 August 2020‐14 August 2020 Symptoms and severity: clinical spectrum of cases (n = 17) was 14 moderate, 2 moderate and 1 severe illness Demographics: mean age: cases 39.6 years, controls 41.2 years M%/F%: cases 58.8/41.2, controls 50.7/49.2 Exposure history: close contact to patients with COVID‐19: cases 13.3%, controls 8.1% |
||
Index tests |
|
||
Target condition and reference standard(s) |
|
||
Flow and timing | Timing not specified | ||
Comparative | |||
Notes | Funding: none declared | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Did the study avoid inappropriate inclusions? | Yes | ||
Could the selection of patients have introduced bias? | Unclear risk | ||
Are there concerns that the included patients and setting do not match the review question? | Low concern | ||
DOMAIN 2: Index Test (All tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | No | ||
Could the conduct or interpretation of the index test have introduced bias? | High risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | Low risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | Unclear risk |